Clinical Trials for Mesothelioma Patients—A Study of Avastin Plus Pemetrexed-Cisplatin

Read about a current clinical trial about the use of Avastin Plus Pemetrexed-Cisplatin Decitabine and FR901228 for patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At the current time, the study is only being conducted in Belgium and France.

Mesothelioma Avastin Plus Pemetrexed-Cisplatin Study (MAPS)

Purpose
Our hypothesis is that the addition of bevacizumab to the standard chemotherapy treatment of MPM will improve overall survival and quality of life beyond that achieved with chemotherapy alone.

Phase, Condition and Intervention
Phase II: Mesothelioma: Drug: Standard Chemotherapy (Pemetrexed and Cisplatin)
Phase II: Mesothelioma: Drug: Standard Chemotherapy (Pemetrexed and Cisplatin) +
Bevacizumab

Study Type and Design:

Interventional; Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title:

A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM)

If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.